The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines (IMAGE)

PLOS

The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines

Caption

Nicotiana benthamiana plant that is ready to be infiltrated to synthesize SARS-CoV2 antigen for use in a plant-based vaccine.

Credit

Allyson MacLean, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.